147 related articles for article (PubMed ID: 10216902)
1. Economic analysis of erythropoietin use in orthopaedic surgery.
Coyle D; Lee KM; Fergusson DA; Laupacis A
Transfus Med; 1999 Mar; 9(1):21-30. PubMed ID: 10216902
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgery.
Coyle D; Lee KM; Fergusson DA; Laupacis A
Pharmacoeconomics; 2000 Aug; 18(2):161-71. PubMed ID: 11067650
[TBL] [Abstract][Full Text] [Related]
3. Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
Tomeczkowski J; Stern S; Müller A; von Heymann C
PLoS One; 2013; 8(9):e72949. PubMed ID: 24039829
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Laupacis A; Fergusson D
Transfus Med; 1998 Dec; 8(4):309-17. PubMed ID: 9881425
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative strategy for homologous blood salvage and peri-operative erythropoietin].
Rosencher N; Woimant G; Ozier Y; Conseiller C
Transfus Clin Biol; 1999 Dec; 6(6):370-9. PubMed ID: 10666795
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Jiang C; Peng H; Feng B; Li Y; Weng X
Medicine (Baltimore); 2016 Jul; 95(27):e4122. PubMed ID: 27399121
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
Quirt I; Micucci S; Moran LA; Pater J; Browman G
Cancer Prev Control; 1997 Aug; 1(3):241-8. PubMed ID: 9765749
[TBL] [Abstract][Full Text] [Related]
8. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis.
Alghamdi AA; Albanna MJ; Guru V; Brister SJ
J Card Surg; 2006; 21(3):320-6. PubMed ID: 16684074
[TBL] [Abstract][Full Text] [Related]
9. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes.
Vitale MG; Roye BD; Ruchelsman DE; Roye DP
Spine J; 2007; 7(3):292-300. PubMed ID: 17482112
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of epoetin and autologous blood donationin reducing allogeneic blood transfusions incoronary artery bypass graft surgery.
Marchetti M; Barosi G
Transfusion; 2000 Jun; 40(6):673-81. PubMed ID: 10864987
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients.
Tonelli M; Winkelmayer WC; Jindal KK; Owen WF; Manns BJ
Kidney Int; 2003 Jul; 64(1):295-304. PubMed ID: 12787422
[TBL] [Abstract][Full Text] [Related]
12. Blood conservation in neurosurgery: erythropoietin and autologous donation.
McGirr A; Pavenski K; Sharma B; Cusimano MD
Can J Neurol Sci; 2014 Sep; 41(5):583-9. PubMed ID: 25373808
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of lenalidomide in the treatment of transfusion-dependent myelodysplastic syndromes in the United States.
Goss TF; Szende A; Schaefer C; Totten PJ; Knight R; Jädersten M; Hellström-Lindberg E; List AF
Cancer Control; 2006 Dec; 13 Suppl():17-25. PubMed ID: 17242663
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review.
Lin DM; Lin ES; Tran MH
Transfus Med Rev; 2013 Oct; 27(4):221-34. PubMed ID: 24135037
[TBL] [Abstract][Full Text] [Related]
15. Blood salvage produces higher total blood product costs in single-level lumbar spine surgery.
Canan CE; Myers JA; Owens RK; Crawford CH; Djurasovic M; Burke LO; Bratcher KR; McCarthy KJ; Carreon LY
Spine (Phila Pa 1976); 2013 Apr; 38(8):703-8. PubMed ID: 23044618
[TBL] [Abstract][Full Text] [Related]
16. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
17. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
Green WS; Toy P; Bozic KJ
J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
[TBL] [Abstract][Full Text] [Related]
18. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
[TBL] [Abstract][Full Text] [Related]
19. [Peri-operative use of EPO].
Rosencher N; Ozier Y
Transfus Clin Biol; 2003 Jun; 10(3):159-64. PubMed ID: 12798850
[TBL] [Abstract][Full Text] [Related]
20. Effect of Erythropoietin on Transfusion Requirements for Craniosynostosis Surgery in Children.
Aljaaly HA; Aldekhayel SA; Diaz-Abele J; Karunanayka M; Gilardino MS
J Craniofac Surg; 2017 Jul; 28(5):1315-1319. PubMed ID: 28582302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
